Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2021 | 1 |
2022 | 4 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivity.
Cell Rep. 2022 Jul 19;40(3):111115. doi: 10.1016/j.celrep.2022.111115.
Cell Rep. 2022.
PMID: 35858552
Free article.
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia.
Hu EY, Do P, Goswami S, Nunes J, Chiang CL, Elgamal S, Ventura AM, Cheney C, Zapolnik K, Williams E, Mani R, Frissora F, Mo X, Waldmeier L, Beerli RR, Peng H, Rader C, Long M, Grawunder U, Byrd JC, Muthusamy N.
Hu EY, et al. Among authors: zapolnik k.
Blood Adv. 2021 Aug 24;5(16):3152-3162. doi: 10.1182/bloodadvances.2020003276.
Blood Adv. 2021.
PMID: 34424320
Free PMC article.
Item in Clipboard
Evaluation of allogeneic and autologous membrane-bound IL-21-expanded NK cells for chronic lymphocytic leukemia therapy.
Yano M, Sharpe C, Lance JR, Ravikrishnan J, Zapolnik K, Mo X, Woyach JA, Sampath D, Kittai AS, Vasu S, Bhat S, Rogers KA, Lee DA, Muthusamy N, Byrd JC.
Yano M, et al. Among authors: zapolnik k.
Blood Adv. 2022 Oct 25;6(20):5641-5654. doi: 10.1182/bloodadvances.2021005883.
Blood Adv. 2022.
PMID: 35486482
Free PMC article.
Item in Clipboard
ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemia.
Goswami S, Chiang CL, Zapolnik K, Nunes J, Ventura A, Mo X, Xie Z, Lee LJ, Baskar S, Rader C, Byrd JC, Phelps M, Bhatnagar B, Muthusamy N.
Goswami S, et al. Among authors: zapolnik k.
Leuk Res. 2022 Jul;118:106872. doi: 10.1016/j.leukres.2022.106872. Epub 2022 May 24.
Leuk Res. 2022.
PMID: 35640397
Free PMC article.
No abstract available.
Item in Clipboard
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia.
Goswami S, Mani R, Nunes J, Chiang CL, Zapolnik K, Hu E, Frissora F, Mo X, Walker LA, Yan P, Bundschuh R, Beaver L, Devine R, Tsai YT, Ventura A, Xie Z, Chen M, Lapalombella R, Walker A, Mims A, Larkin K, Grieselhuber N, Bennett C, Phelps M, Hertlein E, Behbehani G, Vasu S, Byrd JC, Muthusamy N.
Goswami S, et al. Among authors: zapolnik k.
Blood. 2022 Mar 3;139(9):1340-1358. doi: 10.1182/blood.2020010344.
Blood. 2022.
PMID: 34788382
Free PMC article.
Item in Clipboard
Par-4 overexpression impedes leukemogenesis in the Eµ-TCL1 leukemia model through downregulation of NF-κB signaling.
Greene JT, Mani R, Ramaswamy R, Frissora F, Yano M, Zapolnik K, Harrington B, Wasmuth R, Tran M, Mo X, McKenna M, Rangnekar VM, Byrd JC, Bondada S, Muthusamy N.
Greene JT, et al. Among authors: zapolnik k.
Blood Adv. 2019 Apr 23;3(8):1255-1266. doi: 10.1182/bloodadvances.2018025973.
Blood Adv. 2019.
PMID: 30987970
Free PMC article.
Item in Clipboard
Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia.
Mani R, Rajgolikar G, Nunes J, Zapolnik K, Wasmuth R, Mo X, Byrd JC, Lee DA, Muthusamy N, Vasu S.
Mani R, et al. Among authors: zapolnik k.
Cytotherapy. 2020 Jul;22(7):369-376. doi: 10.1016/j.jcyt.2020.02.001. Epub 2020 Apr 15.
Cytotherapy. 2020.
PMID: 32303428
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite